Suzanne Bruhn, Ph.D.
DirectoratDefinium Therapeutics· In proxies 2023–2025
Suzanne Bruhn, Ph.D. sits on 13 public boards.
Boards2
- Travere TherapeuticsDirector · 5 yr on the boardIndependentCompensation, Science and Medical Technology—Paid as an executive
- Definium TherapeuticsDirector · 3 yr on the boardIndependentCompensation (Chair), Nominating and Corporate Governance—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Definium TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +1,578%
- Travere TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
- Pliant TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
- Vigil NeurosciencePublic company · 4 yr
- Director2022 – Present · 4 yrNo stock prices for these years
- Pliant Therapeutics, Inc.Public company · 10 yr
- Director2016 – Present · 10 yrNo stock prices for these years
- Definium Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Mind Medicine Inc.Public company
- Director? – PresentNo stock prices for these years
- Raptor Pharmaceuticals Corp.Public company · 15 yr
- Director2011 – Present · 15 yrNo stock prices for these years
- Avalo Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Avalo Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Cerecor, Inc.Public company · 1 yr
- Director2020 – 2021 · 1 yrNo stock prices for these years
- Aeglea BioTherapeutics, Inc.Public company · 3 yr
- Director2017 – 2020 · 3 yrNo stock prices for these years
- Novelion Therapeutics, Inc.Public company · 3 yr
- Director2017 – 2020 · 3 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?